Suspected chylothorax (adult)
Milky or persistent pleural or chest-drain fluid, often after thoracic surgery. Adults only.
All Pathways
Cardiothoracic SurgeryManagement
Adult Chylothorax Management (JTD 2024 review)
Adult Chylothorax Management (JTD 2024 review): Suspected chylothorax (adult) → Confirm chyle: pleural fluid triglyceride and cholesterol → Adults only....
Pathway Overview
14 steps
Algorithm Steps
14 total
01Start 02Action Confirm chyle: pleural fluid triglyceride and cholesterol
Send triglyceride, cholesterol, cell count and cytology. Clear fluid does not exclude chyle.
- Triglyceride >1.24 mmol/L (110 mg/dL) and cholesterol <5.18 mmol/L (200 mg/dL): chylothorax
- Triglyceride 0.56-1.24 mmol/L (50-110 mg/dL), or patient fasting or malnourished: test for chylomicrons (lipoprotein electrophoresis)
- Cholesterol >5.18 mmol/L or cholesterol crystals, triglyceride usually <0.56 mmol/L: pseudochylothorax, not chyle; this pathway does not apply
- Triglyceride <0.56 mmol/L and cholesterol normal: chyle unlikely unless fasting or malnourished
- Usually a lymphocyte-predominant exudate; only 22-44% look milky
03Warning Adults only. Chyle loss causes malnutrition, immune loss and drug loss
Pseudochylothorax (cholesterol effusion) is not chyle: stop this pathway. Check the points below before and during treatment.
- Children and neonates: use a paediatric protocol (thresholds and doses differ)
- Monitor daily drain output, weight, electrolytes, albumin and lymphocyte count
- Amiodarone, digoxin and ciclosporin are lost in chyle: check levels or effect
04Decision Post-surgical or traumatic leak?
Oesophagectomy (highest risk), lung resection, cardiac or aortic surgery, neck surgery, chest injury. Central vein thrombosis is a No: treat the thrombosis.
- If Yes
05Action Conservative care: drain, diet, octreotide
First line for most leaks. Replace drain losses: chyle is rich in protein and electrolytes. Octreotide: caution in vascular disease; it can cause bradycardia and high or low glucose.
- Drain the effusion; a chest drain lets you measure daily output (cirrhosis: avoid a chest drain)
- Low output: dietitian review; low-fat, high-protein diet with MCT; add fat-soluble vitamins
- High output (>1 L/day) or diet fails: nil by mouth and TPN (risks: line infection, cholestasis); replace losses with IV fluid and electrolytes
- Octreotide SC (off-label; regimens vary): dose per specialist or local protocol. Monitor heart rate (care with beta-blockers or amiodarone) and glucose
- Chest drain usually for less than 2 weeks; shorter if frail
06Decision High output: over 1 L/day?
Measure 24-hour drain output on conservative care
- If Yes
07Action Post-surgical high output (>1 L/day): plan early TDE or duct ligation
Less likely to settle with conservative care. Refer to thoracic surgery and interventional radiology now. Non-traumatic cause: treat the cause first; MDT decides on intervention.
- Continue nil by mouth, TPN and octreotide while you plan
- Intervene if output does not fall within about 1 week
- After oesophagectomy: involve the oesophageal surgeon early; do not wait weeks
- Intervene sooner for nutritional, immune or respiratory decline
08Action Persistent or high-output leak: thoracic duct embolisation (TDE)
Interventional radiology. Avoid with untreated coagulopathy or abdominal lesions such as aortic aneurysm (transabdominal access). Lipiodol lymphangiography: not with a right-to-left cardiac shunt or advanced lung disease (oil embolism); caution with iodine contrast allergy.
- Intranodal (or pedal) lymphangiography, then thoracic duct cannulation and coil or glue embolisation
- Lymphangiography alone closes some leaks
- Best results in traumatic (post-surgical) leaks; less effective in non-traumatic
- Pooled clinical success about 60% overall, about 80% when the duct is embolised; major complications about 2%
- Needs a centre with lymphatic intervention expertise
09Action TDE failed or not available: thoracic duct ligation
Definitive surgical option: VATS, robotic or thoracotomy.
- Usually right-sided mass ligation just above the diaphragm, between aorta and azygos vein
- Cream or fat meal before surgery, or ICG, helps show the leak
- Success >90% in traumatic leaks; mortality about 3%
10Action Leak persists or not fit for surgery: pleurodesis or IPC
Consider when conservative care fails and surgery is not suitable.
- Talc pleurodesis (slurry or thoracoscopic)
- Needs lung re-expansion; less effective in high-output leaks
- Recurrent or malignant chylothorax: indwelling pleural catheter is an option
11Outcome Chylothorax resolved
Resume normal diet and watch drain or effusion for recurrence.
If No12Action Low output (<1 L/day): continue conservative care
Reassess output, nutrition and bloods every day.
- Consider intervention if the leak persists after about 2 weeks
- Intervene sooner if output rises above 1 L/day
- Intervene sooner for nutritional, immune or respiratory decline
13Decision Leak persists or patient declining?
Despite conservative care. Yes: thoracic duct embolisation (TDE) step. No, leak settled: chylothorax resolved step.
- If Yes
- Path rejoins step 08Shared downstream outcome
If No- Path rejoins step 11Shared downstream outcome
If No14Action Non-traumatic: find and treat the cause
CT chest and abdomen and pleural cytology. Cirrhosis: avoid a chest drain (risk of empyema, bleeding, renal failure). Then use the conservative care step.
- Causes: lymphoma (most common) or other cancer, central vein thrombosis or obstruction, heart failure, cirrhosis, LAM, sarcoidosis, TB, idiopathic
- Treat the cause: e.g. chemotherapy or radiotherapy for lymphoma, anticoagulation for central vein thrombosis, diuretics in heart failure, sirolimus in LAM
- Symptomatic effusion: therapeutic thoracocentesis, indwelling pleural catheter or chest drain. Cirrhosis: avoid a chest drain; get hepatology advice
- No cause found: lymphatic imaging (CT or MR lymphangiography, lymphoscintigraphy)
- Path rejoins step 05Shared downstream outcome
Guideline Source
Bhatnagar M et al. Chylothorax: pathophysiology, diagnosis, and management - a comprehensive review. J Thorac Dis 2024;16(2):1645-1661
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- No formal guideline or RCTs: based on a 2024 review, systematic reviews and case series.
- Adults only. Timing of TDE or ligation, mainly after oesophagectomy, varies between centres.
- TDE needs lymphatic intervention expertise, which is not available in every centre.
- Definition of high output varies (500-1500 mL/day); this pathway uses more than 1 L/day.
Contraindicated Populations
children and neonatespseudochylothorax
Applicable Regions
USEUAU
AU: Pleural lipids are reported in mmol/L (triglyceride 1.24 mmol/L = 110 mg/dL; cholesterol 5.18 mmol/L = 200 mg/dL). Octreotide is on the ARTG but chylothorax is an off-label use. Somatostatin is not on the ARTG.
Version 2Next review: 2027-09-30
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Adult Chylothorax Management (JTD 2024 review)?
The Adult Chylothorax Management (JTD 2024 review) is a management clinical algorithm for Cardiothoracic Surgery. It provides a structured decision tree to guide clinical decision-making, based on Bhatnagar M et al. Chylothorax: pathophysiology, diagnosis, and management - a comprehensive review. J Thorac Dis 2024;16(2):1645-1661.
What guideline is the Adult Chylothorax Management (JTD 2024 review) based on?
This algorithm is based on Bhatnagar M et al. Chylothorax: pathophysiology, diagnosis, and management - a comprehensive review. J Thorac Dis 2024;16(2):1645-1661 (DOI: 10.21037/jtd-23-1636).
What are the limitations of the Adult Chylothorax Management (JTD 2024 review)?
Known limitations include: No formal guideline or RCTs: based on a 2024 review, systematic reviews and case series.; Adults only. Timing of TDE or ligation, mainly after oesophagectomy, varies between centres.; TDE needs lymphatic intervention expertise, which is not available in every centre.; Definition of high output varies (500-1500 mL/day); this pathway uses more than 1 L/day.. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Adult Chylothorax Management (JTD 2024 review) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free